PPKs constitute a heterogeneous group of disorders characterized by thickening of the palms and soles. The condition may either be hereditary or acquired and in the form of associated syndrome(s ...
A 21-year-old Muslim, the product of a consanguineous marriage (paternal and maternal grandmothers were sisters) developed progressive papular and erythematosquamous rash over his abdomen on ...
Prof. Adam Reich reviewed itch in psoriasis, while Dr. Anushka Irani discussed the connection between pain and psoriatic ...
A blister (vesicle) is a small pocket of fluid that forms beneath the skin as a result of an injury, but also allergic ...
A dermatologist in Bangladesh has diagnosed the family's condition as congenital palmoplantar keratoderma, which Prof Itin believes developed into secondary Adermatoglyphia - a version of the ...
Palmoplantar Keratoderma, Epidermolysis Bullosa and others. For more information, go to: www.quoinpharma.com. Cautionary Note Regarding Forward Looking Statements The Company cautions that ...
On September 3 and 4, 2024, Michael Myers, CEO of Quoin Pharmaceuticals, acquired a total of 37,894 ADSs at prices ranging from $0.619 to $0.7974 per ADS. Similarly, COO Denise Carter acquired a total ...
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
Meanwhile, spesolimab is also being tested to potentially treat other skin diseases, such as palmoplantar pustulosis and hidradenitis suppurativa. Following after Boehringer in the GPP category is ...
A WOMAN from Prestatyn has pleaded for help from Denbighshire County Council (DCC) with her waste collections after her skin condition has left her struggling with a new system implemented.
Other potential disease targets include palmoplantar pustulosis, generalised pustular psoriasis and pyoderma gangrenosum. Several further phase 2 trials are planned soon, the company said.
The recent insider purchases signal strong internal confidence in Quoin Pharmaceuticals’ strategy and potential. As the company continues to develop its therapeutic pipeline, these insider ...